1. New Psoriasis Treatments

2. This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States and data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.

3. Case: Ron

4. Ron: History and Physical Examination

5. Impact of Psoriasis on Ron

6. Ron: Assessment

7. Evaluating for Psoriatic Arthritis

8. Ron's CV Risk

9. Improving Treatment Selection for Ron

10. Case: Miranda

11. Miranda: History and Physical Examination

12. Impact of Psoriasis on Miranda

13. Miranda: Assessment

14. Measuring Disease Severity

15. Gastrointestinal Symptoms

16. Psychosocial Impact

17. Treatment Choices for a Woman of Childbearing Age

18. Case: Marcus

19. Marcus: History and Physical Examination

20. Impact of Psoriasis on Marcus

21. Marcus: Assessment

22. Itch and Psoriasis

23. Systemic Therapies in a Patient With a Prior Cancer Diagnosis

24. Insurance Coverage

25. Key Take Home Points

26. Abbreviations